OQROSign up free
Politician trade (House)

Eli Lilly (LLY): Rep. Jared Moskowitz (FL23) disclosed a purchase $1K–$15K

Rep. Jared Moskowitz (FL23) disclosed a purchase of Eli Lilly in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
25 days
Disclosure lag
Traded
Dec 28, 2023
Disclosed
Jan 22, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 26, 2023CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  2. Oct 3, 2023CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  3. Oct 11, 2023CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  4. Oct 24, 2023CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  5. Nov 8, 2023FDAFDA drug approval: Zepbound
  6. Nov 13, 2023CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  7. Nov 16, 2023CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  8. Dec 4, 2023CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  9. Dec 14, 2023CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  10. Dec 28, 2023 · this disclosureCongressDisclosed purchase of LLY — reported range $1,001 - $15,000

What came next

  1. Dec 28, 2023CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  2. Jan 3, 2024CongressDisclosed partial sale of LLY — reported range $15,001 - $50,000
  3. Feb 8, 2024CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  4. Mar 12, 2024FDARecall: Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY w…
  5. Apr 10, 2024FDAFDA drug approval: Retevmo
  6. Apr 10, 2024CongressDisclosed sale of LLY — reported range $1,001 - $15,000
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by Rep. Jared Moskowitz (FL23)

The full history of Rep. Jared Moskowitz (FL23) is on the profile page.

How this filing works

Explore the data

Other disclosures at Eli Lilly

Everything OQRO holds on this company is on its LLY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data